- $132.52m
- $29.27m
- $27.86m
- 54
- 45
- 58
- 52
Annual income statement for Compugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2 | 6 | 7.5 | 33.5 | 27.9 |
| Cost of Revenue | |||||
| Gross Profit | 1.94 | 5.32 | 6.53 | 31.5 | 19.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 33.5 | 41.1 | 42.9 | 46.5 | 42.8 |
| Operating Profit | -31.5 | -35.1 | -35.4 | -13 | -14.9 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -29.7 | -34.2 | -33.6 | -9.78 | -9.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.7 | -34.2 | -33.7 | -18.8 | -14.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.7 | -34.2 | -33.7 | -18.8 | -14.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.7 | -34.2 | -33.7 | -18.8 | -14.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.373 | -0.406 | -0.389 | -0.211 | -0.155 |
| Dividends per Share |